同一家族,不同物种:五种知识合成方法的方法学实施与质量因目的而异
该研究对五种知识合成方法(综述概览、范围综述、快速综述、系统综述和网状Meta分析)的已发表数据库进行回顾性分析,使用AMSTAR工具评价方法学实施、报告和质量。结果显示,方案使用率从快速综述的4%到系统综述的32%不等;AMSTAR评分中位数最高为网状Meta分析(64%),最低为范围综述(25%)。
要点
- 方案使用率范围:快速综述4%至系统综述32%
- 文献筛选双人独立率:范围综述20%至网状Meta分析60%
- AMSTAR中位评分:网状Meta分析64%,范围综述25%
核心结论
- 网状Meta分析在AMSTAR工具上得分最高,可能因为其目的是统计估计治疗效果;范围综述得分最低,可能因为其目的是描述文献特征。
研究设计与样本
- 回顾性分析五个已发表的知识合成方法数据库的便利样本:综述概览(n=74)、范围综述(n=494)、快速综述(n=84)、系统综述(n=300)和网状Meta分析(n=456)。
主要发现
- 报告使用方案的比例从快速综述的4%到系统综述的32%。
- 使用两名评价员进行引文和全文筛选的比例从范围综述的20%到网状Meta分析的60%。
- 数据提取重复进行的比例:快速综述11%,网状Meta分析54%。
- 偏倚风险评估重复进行的比例从范围综述的6%到网状Meta分析的41%。
- AMSTAR评分中位数百分比:网状Meta分析最高(64%;Q1-Q3:45-73%),范围综述最低(25%;Q1-Q3:13-38%)。
关键数值与推荐
- 报告使用方案的比例:快速综述4%,系统综述32%。
- 双人引文和全文筛选的比例:范围综述20%,网状Meta分析60%。
- 数据提取重复进行的比例:快速综述11%,网状Meta分析54%。
- 偏倚风险评估重复进行的比例:范围综述6%,网状Meta分析41%。
- AMSTAR评分中位数百分比:网状Meta分析64%(Q1-Q3:45-73%),范围综述25%(Q1-Q3:13-38%)。
临床怎么用
- 在解读不同知识合成方法的结果时,应考虑其方法学实施和报告质量的差异,尤其是AMSTAR评分所反映的质量水平。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of the study was to characterize methodological conduct, reporting, and quality of five knowledge synthesis (KS) approaches. STUDY DESIGN AND SETTING: Retrospective analysis of a convenience sample of five published databases of KS approaches: overview of reviews (n = 74), scoping reviews (n = 494), rapid reviews (n = 84), systematic reviews (n = 300), and network meta-analyses (NMAs; n = 456). Data in the five published databases were abstracted by two reviewers independently, any missing data for this retrospective analysis were abstracted by one experienced reviewer. Methods were appraised using the A MeaSurement Tool to Assess systematic Reviews (AMSTAR) tool. Descriptive analysis was performed. RESULTS: Reporting the use of a protocol ranged from 4% for rapid reviews to 32% for systematic reviews. The use of two reviewers for citation and full-text screening ranged from 20% for scoping reviews to 60% for NMAs. Data abstraction was performed in duplicate for 11% of rapid reviews and 54% of NMAs, and for risk of bias appraisal, this ranged from 6% for scoping reviews to 41% for NMAs. NMAs had the highest median percentage of maximum obtainable AMSTAR score (64%; Q1-Q3:45-73%), while scoping reviews had the lowest (25%; Q1-Q3:13-38%). CONCLUSION: NMAs consistently scored the highest on the AMSTAR tool likely because the purpose is to estimate treatment effects statistically. Scoping reviews scored the lowest (even after adjusting the score for not relevant items) likely because the purpose is to characterize the literature.
引用
- Tricco AC, Zarin W, Ghassemi M, et al. Same family, different species: methodological conduct and quality varies according to purpose for five types of knowledge synthesis. J Clin Epidemiol. 2017. PMID: 29103958. doi:10.1016/j.jclinepi.2017.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。